Last update: 7:00PM
Agile Therapeutics
(OTCPK:AGRX)Agile Therapeutics Stock (OTC:AGRX), Earnings Estimates, EPS, and Revenue
Agile Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 28
EPS Estimate
$-0.510
Quarterly Revenue Estimate
$3.8M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$19.6M
Analyze the earnings history of Agile Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Agile Therapeutics (OTCPK:AGRX) reporting earnings?
Agile Therapeutics (AGRX) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Agile Therapeutics (OTCPK:AGRX)?
The Actual EPS was $-1.46, which missed the estimate of $-0.92.
What were Agile Therapeutics’s (OTCPK:AGRX) revenues?
The Actual Revenue was $3.6M, which missed the estimate of $4.1M.
Browse earnings estimates, EPS, and revenue on all stocks.